The road to a COVID-19 treatment launch
Executive Q&A: How pharma's supply chain partners are paving the way for coronavirus therapies
Leaders from AmerisourceBergen’s Strategic Global Sourcing team share their perspective on how we’ll make sure the right pieces are in place as manufacturers seek to commercialize new therapies. You'll get firsthand insight on:
What we've learned from efforts to ensure supply chain stability at the height of the coronavirus pandemic
How COVID-19 was a significant force for innovation in the supply chain
The impact of emergency use authorizations (EUAs) on distribution planning and partnerships
Complete the form below to download this Q&A today, then continue the conversation by reaching out to our experts.